Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond.
Jonathan CorrenChristopher E BrightlingLouis-Philippe BouletCeleste PorsbjergMichael E WechslerAndrew Menzies-GowChristopher S AmbroseBill CookNeil MartinJoseph SpahnJean-Pierre LlanosPublished in: The European respiratory journal (2023)